COVID-19-associated cardiogenic shock

Jump to navigation Jump to search

WikiDoc Resources for COVID-19-associated cardiogenic shock

Articles

Most recent articles on COVID-19-associated cardiogenic shock

Most cited articles on COVID-19-associated cardiogenic shock

Review articles on COVID-19-associated cardiogenic shock

Articles on COVID-19-associated cardiogenic shock in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on COVID-19-associated cardiogenic shock

Images of COVID-19-associated cardiogenic shock

Photos of COVID-19-associated cardiogenic shock

Podcasts & MP3s on COVID-19-associated cardiogenic shock

Videos on COVID-19-associated cardiogenic shock

Evidence Based Medicine

Cochrane Collaboration on COVID-19-associated cardiogenic shock

Bandolier on COVID-19-associated cardiogenic shock

TRIP on COVID-19-associated cardiogenic shock

Clinical Trials

Ongoing Trials on COVID-19-associated cardiogenic shock at Clinical Trials.gov

Trial results on COVID-19-associated cardiogenic shock

Clinical Trials on COVID-19-associated cardiogenic shock at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on COVID-19-associated cardiogenic shock

NICE Guidance on COVID-19-associated cardiogenic shock

NHS PRODIGY Guidance

FDA on COVID-19-associated cardiogenic shock

CDC on COVID-19-associated cardiogenic shock

Books

Books on COVID-19-associated cardiogenic shock

News

COVID-19-associated cardiogenic shock in the news

Be alerted to news on COVID-19-associated cardiogenic shock

News trends on COVID-19-associated cardiogenic shock

Commentary

Blogs on COVID-19-associated cardiogenic shock

Definitions

Definitions of COVID-19-associated cardiogenic shock

Patient Resources / Community

Patient resources on COVID-19-associated cardiogenic shock

Discussion groups on COVID-19-associated cardiogenic shock

Patient Handouts on COVID-19-associated cardiogenic shock

Directions to Hospitals Treating COVID-19-associated cardiogenic shock

Risk calculators and risk factors for COVID-19-associated cardiogenic shock

Healthcare Provider Resources

Symptoms of COVID-19-associated cardiogenic shock

Causes & Risk Factors for COVID-19-associated cardiogenic shock

Diagnostic studies for COVID-19-associated cardiogenic shock

Treatment of COVID-19-associated cardiogenic shock

Continuing Medical Education (CME)

CME Programs on COVID-19-associated cardiogenic shock

International

COVID-19-associated cardiogenic shock en Espanol

COVID-19-associated cardiogenic shock en Francais

Business

COVID-19-associated cardiogenic shock in the Marketplace

Patents on COVID-19-associated cardiogenic shock

Experimental / Informatics

List of terms related to COVID-19-associated cardiogenic shock

For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Alieh Behjat, M.D.[2]

Synonyms and keywords:: Novel coronavirus, COVID-19, Wuhan coronavirus, coronavirus disease-19, coronavirus disease 2019, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, cardiovascular finding in COVID-19, cardiogenic shock, COVID-19 associated cardiogenic shock

Overview

In Italy, for the first time in a 69-year-old patient, who was presented with cardiogenic shock due to COVID-19 infection myocardial involvement by viral particles was pathologically proved through biopsy. Two mechanisms are more probable to contribute to cardiogenic shock related to Covid-19 that includes direct invasion and cytokine storm. According to a recent study, one-third of critically ill patients with COVID-19 of an ICU in Washington State had clinical signs of cardiogenic shock and cardiomyopathy. According to an observational study in China, COVID-19 associated cardiogenic shock has a poor prognosis.

Historical Perspective

  • In December 2019, a novel coronavirus named SARS-CoV-2 resulted in Coronavirus disease 2019, which caused respiratory disease outbreak identified firstly in Wuhan, China.[1][2]
  • On March 12, 2020, the WHO declared coronavirus disease 2019(COVID-19) outbreak to be a pandemic.[3]
  • In Italy, for the first time in a 69-year-old patient, who was presented with cardiogenic shock due to COVID-19 infection, myocardial involvement by viral particles was pathologically proved through biopsy. [4]
  • To view the historical perspective of COVID-19, click here.

Classification

Pathophysiology

Two mechanisms are more probable to contribute to cardiogenic shock related to Covid-19:[5] [6]

Causes

The causes of cardiogenic shock related to COVID-19 might include: [7] [8]

Differentiating COVID-19 associated cardiogenic shock from other Diseases

Cardiogenic shock related to COVID-19 must be differentiated from other diseases which include: [9] [10]

Some hemodynamic parameters would help differentiate significant types of shock: [11]

Cardiac Output Pulmonary Capillary Wedge Pressure Systemic Vascular Resistance Pulmonary artery diastolic pressure SVO2
COVID-19-associated cardiogenic shock ↑↔
Septic shock
Hypovolemic shock

Epidemiology and Demographics

Age

Gender

Race

Risk Factors

  • There are no established risk factors for COVID-19-associated cardiogenic shock.
  • To view risk factors for the severe form of COVID-19 disease, click here.
  • Moreover, in order to read more on the risk factors of cardiogenic shock, generally, click here.

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms:

  • A 69-year-old patient from Italy has been reported by Tavazzi et al., as a cardiogenic shock-associated COVID-19 case.
  • The patient had flu-like symptoms when he was hospitalized and quickly deteriorated into respiratory distress and cardiogenic shock. [4]
  • Four patients with cardiogenic shock complication related to COVID-19 were reported by Sanchez-Recalde, et al.
  • They were hospitalized between 1 March and 15 April 2020 including:[13]

Physical Examination

Physical examination may be remarkable for Covid-19 associated cardiogenic shock:[16]

Laboratory Findings

  • The increase of some biomarkers demonstrates poor prognosis, increased mortality, and more severe symptoms in COVID-19 patients:[18]

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

  • Generally, the CT scan is not suggested being a primary imaging study, for evaluating a case with cardiogenic shock related to COVID-19. However, it can be suggestive of a coexisting ARDS by demonstrating a ground-glass opacity.[20]
  • To view the CT scan findings on COVID-19, click here.

MRI

Other Imaging Findings

  • To view other imaging findings on COVID-19, click here.

Other Diagnostic Studies

  • To view other diagnostic studies for COVID-19, click here.

Treatment

Cardiogenic shock medical therapy:

Mechanical Support:

  • In treating patients with cardiogenic shock related to COVID-19, the efficacy of extracorporeal membrane oxygenation (ECMO) is indistinct.
  • It might be used in most critically ill and highly selective patients.
  • Although specialists implicate ECMO and mechanical circulatory support devices in severe patients with cardiogenic shock related to COVID-19, most of these cases die.
  • It has been reported in a case series from China that most of these patients had a poor prognosis and did not survive despite implicating ECMO. [22] [14]

Surgery

Primary Prevention

Secondary Prevention

  • There are no established measures for the secondary prevention of COVID-19-associated myocarditis.
  • For secondary preventive measures of [COVID-19], click here.

References

  1. https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. Missing or empty |title= (help)
  2. Lu, Jian; Cui, Jie; Qian, Zhaohui; Wang, Yirong; Zhang, Hong; Duan, Yuange; Wu, Xinkai; Yao, Xinmin; Song, Yuhe; Li, Xiang; Wu, Changcheng; Tang, Xiaolu (2020). "On the origin and continuing evolution of SARS-CoV-2". National Science Review. doi:10.1093/nsr/nwaa036. ISSN 2095-5138.
  3. "Coronavirus (COVID-19) events as they happen".
  4. 4.0 4.1 4.2 Tavazzi, Guido; Pellegrini, Carlo; Maurelli, Marco; Belliato, Mirko; Sciutti, Fabio; Bottazzi, Andrea; Sepe, Paola Alessandra; Resasco, Tullia; Camporotondo, Rita; Bruno, Raffaele; Baldanti, Fausto; Paolucci, Stefania; Pelenghi, Stefano; Iotti, Giorgio Antonio; Mojoli, Francesco; Arbustini, Eloisa (2020). "Myocardial localization of coronavirus in COVID‐19 cardiogenic shock". European Journal of Heart Failure. 22 (5): 911–915. doi:10.1002/ejhf.1828. ISSN 1388-9842.
  5. Siddiqi, Hasan K.; Mehra, Mandeep R. (2020). "COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal". The Journal of Heart and Lung Transplantation. 39 (5): 405–407. doi:10.1016/j.healun.2020.03.012. ISSN 1053-2498.
  6. Ye, Qing; Wang, Bili; Mao, Jianhua (2020). "The pathogenesis and treatment of the `Cytokine Storm' in COVID-19". Journal of Infection. 80 (6): 607–613. doi:10.1016/j.jinf.2020.03.037. ISSN 0163-4453.
  7. Mahajan, Kunal; Chandra, K.Sarat (2020). "Cardiovascular comorbidities and complications associated with coronavirus disease 2019". Medical Journal Armed Forces India. doi:10.1016/j.mjafi.2020.05.004. ISSN 0377-1237.
  8. Belhadjer, Zahra; Méot, Mathilde; Bajolle, Fanny; Khraiche, Diala; Legendre, Antoine; Abakka, Samya; Auriau, Johanne; Grimaud, Marion; Oualha, Mehdi; Beghetti, Maurice; Wacker, Julie; Ovaert, Caroline; Hascoet, Sebastien; Selegny, Maëlle; Malekzadeh-Milani, Sophie; Maltret, Alice; Bosser, Gilles; Giroux, Nathan; Bonnemains, Laurent; Bordet, Jeanne; Di Filippo, Sylvie; Mauran, Pierre; Falcon-Eicher, Sylvie; Thambo, Jean-Benoît; Lefort, Bruno; Moceri, Pamela; Houyel, Lucile; Renolleau, Sylvain; Bonnet, Damien (2020). "Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic". Circulation. doi:10.1161/CIRCULATIONAHA.120.048360. ISSN 0009-7322.
  9. Boukhris, Marouane; Hillani, Ali; Moroni, Francesco; Annabi, Mohamed Salah; Addad, Faouzi; Ribeiro, Marcelo Harada; Mansour, Samer; Zhao, Xiaohui; Ybarra, Luiz Fernando; Abbate, Antonio; Vilca, Luz Maria; Azzalini, Lorenzo (2020). "Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective". Canadian Journal of Cardiology. doi:10.1016/j.cjca.2020.05.018. ISSN 0828-282X.
  10. Rajagopal, Keshava; Keller, Steven P.; Akkanti, Bindu; Bime, Christian; Loyalka, Pranav; Cheema, Faisal H.; Zwischenberger, Joseph B.; El Banayosy, Aly; Pappalardo, Federico; Slaughter, Mark S.; Slepian, Marvin J. (2020). "Advanced Pulmonary and Cardiac Support of COVID-19 Patients". Circulation: Heart Failure. 13 (5). doi:10.1161/CIRCHEARTFAILURE.120.007175. ISSN 1941-3289.
  11. Jameson, J (2018). Harrison's principles of internal medicine. New York: McGraw-Hill Education. ISBN 1259644030.
  12. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M; et al. (2020). "Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State". JAMA. doi:10.1001/jama.2020.4326. PMC 7082763 Check |pmc= value (help). PMID 32191259 Check |pmid= value (help).
  13. 13.0 13.1 Sánchez-Recalde, Ángel; Solano-López, Jorge; Miguelena-Hycka, Javier; Martín-Pinacho, Jesús Javier; Sanmartín, Marcelo; Zamorano, José L. (2020). "COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality". Revista Española de Cardiología (English Edition). doi:10.1016/j.rec.2020.04.012. ISSN 1885-5857.
  14. 14.0 14.1 Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H; et al. (2020). "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study". Lancet Respir Med. 8 (5): 475–481. doi:10.1016/S2213-2600(20)30079-5. PMC 7102538 Check |pmc= value (help). PMID 32105632 Check |pmid= value (help).
  15. 15.0 15.1 Dhakal, Bishnu P.; Sweitzer, Nancy K.; Indik, Julia H.; Acharya, Deepak; William, Preethi (2020). "SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart". Heart, Lung and Circulation. doi:10.1016/j.hlc.2020.05.101. ISSN 1443-9506.
  16. Tse, FirstName (2011). Oxford Desk Reference : Cardiology. Oxford: OUP Oxford. ISBN 978-0-19-956809-3.
  17. 17.0 17.1 Lal, Sean; Hayward, Christopher S.; De Pasquale, Carmine; Kaye, David; Javorsky, George; Bergin, Peter; Atherton, John J.; Ilton, Marcus K.; Weintraub, Robert G.; Nair, Priya; Rudas, Mate; Dembo, Lawrence; Doughty, Robert N.; Kumarasinghe, Gayathri; Juergens, Craig; Bannon, Paul G.; Bart, Nicole K.; Chow, Clara K.; Lattimore, Jo-Dee; Kritharides, Leonard; Totaro, Richard; Macdonald, Peter S. (2020). "COVID-19 and Acute Heart Failure: Screening the Critically Ill – A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ)". Heart, Lung and Circulation. doi:10.1016/j.hlc.2020.04.005. ISSN 1443-9506.
  18. Aboughdir, Maryam; Kirwin, Thomas; Abdul Khader, Ashiq; Wang, Brian (2020). "Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review". Viruses. 12 (5): 527. doi:10.3390/v12050527. ISSN 1999-4915.
  19. Tse, FirstName (2011). Oxford Desk Reference : Cardiology. Oxford: OUP Oxford. ISBN 978-0-19-956809-3.
  20. 20.0 20.1 Driggin, Elissa; Madhavan, Mahesh V.; Bikdeli, Behnood; Chuich, Taylor; Laracy, Justin; Biondi-Zoccai, Giuseppe; Brown, Tyler S.; Der Nigoghossian, Caroline; Zidar, David A.; Haythe, Jennifer; Brodie, Daniel; Beckman, Joshua A.; Kirtane, Ajay J.; Stone, Gregg W.; Krumholz, Harlan M.; Parikh, Sahil A. (2020). "Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic". Journal of the American College of Cardiology. 75 (18): 2352–2371. doi:10.1016/j.jacc.2020.03.031. ISSN 0735-1097.
  21. 21.0 21.1 Dhakal BP, Sweitzer NK, Indik JH, Acharya D, William P (2020). "SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart". Heart Lung Circ. doi:10.1016/j.hlc.2020.05.101. PMC 7274628 Check |pmc= value (help). PMID 32601020 Check |pmid= value (help).
  22. MacLaren, Graeme; Fisher, Dale; Brodie, Daniel (2020). "Preparing for the Most Critically Ill Patients With COVID-19". JAMA. 323 (13): 1245. doi:10.1001/jama.2020.2342. ISSN 0098-7484.

Template:WS Template:WH